Tempus AI, Inc.
HealthcareNASDAQ:TEM · NASDAQ Global Select
-$1.77 today
Vol 5.92M · Avg 6.00M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-49.9%
avg -163.3%
ROIC
-10.3%
avg -51.1%
ROA
-10.8%
avg -39.8%
Analysis
ROIC is currently the strongest return metric at -10.3% versus its period average of -51.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Eric Lefkofsky | Co-Founder, Chief Executive Officer, President & Chairman | $1.50M | — | 56 | $8.83M | 5.06% |
Erik Phelps | Executive VP and Chief Administrative & Legal Officer | $983,271.00 | — | 55 | $85,466.00 | 0.05% |
Ryan Fukushima | Chief Executive Officer of Data & Apps | $948,307.00 | — | 40 | $603,558.00 | 0.35% |
Andrew Polovin | General Counsel | $884,500.00 | — | 52 | $128,215.00 | 0.07% |
James Rogers | Chief Financial Officer | $725,000.00 | — | 39 | $126,395.00 | 0.07% |
Ezra Cohen | Chief Medical Officer of Oncology | — | — | — | — | — |
Kate A. Sasser | Chief Scientific Officer | — | — | 48 | — | — |
Greg Fisbeck | Chief Information Security Officer | — | — | — | — | — |
Ryan Bartolucci | Chief Accounting Officer | — | — | 44 | $603,558.00 | 0.35% |
Christina Antoniou | Senior Vice President & Head of Corporate Development | — | — | — | — | — |
Lauren R. Silvis | Senior Vice President of External Affairs | — | — | — | — | — |
Patty Spiller | Chief Marketing Officer | — | — | — | — | — |
Robyn Eckerling | Chief Privacy Officer | — | — | — | — | — |
Stacey Kraft | Chief People Officer | — | — | — | — | — |
Shane Colley | Chief Technology Officer | — | — | — | — | — |
Melisa Tucker | Chief Data Officer | — | — | — | — | — |
Elizabeth Krutoholow | Vice President of Investor Relations & Competitive Intelligence | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
176
$211.58M
Net Sentiment
$211.58M
Net selling
Most Active
LEFKOFSKY ERIC P
102 transactions
1–10 of 176
Analysis
Insiders reported 0 buys worth $0.00 and 176 sells worth $211.58M over the last 12 months. That adds up to net selling of $211.58M. LEFKOFSKY ERIC P was the most active insider with 102 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A6 analysts |
| Revenue | N/A | N/A | +41.4% | +28.8% (7yr)5 analysts |
| Net Income | N/A | N/A | N/A | N/A5 analysts |
| EBIT | N/A | N/A | N/A | N/A5 analysts |
Analysis
Recent growth has been strongest in Revenue at +41.4% over three years. Forward estimates point to Revenue at +28.8% (7yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Centene Corporation
NYSE:CNC
$32.19B
Hologic, Inc.
HOLX
$16.97B
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
$16.06B
Medpace Holdings, Inc.
NASDAQ:MEDP
$13.35B
The Cooper Companies, Inc.
NASDAQ:COO
$13.24B
Smith & Nephew plc
NYSE:SNN
$12.97B
Fresenius Medical Care AG & Co. KGaA
NYSE:FMS
$12.36B
ICON Public Limited Company
NASDAQ:ICLR
$11.19B
Universal Health Services, Inc.
NYSE:UHS
$9.17B
Doximity, Inc.
NYSE:DOCS
$3.75B
Who manages TEM?
Tempus AI, Inc. (TEM) lists 17 active executives. The top listed executive is Ezra Cohen, Chief Medical Officer of Oncology.
Are TEM insiders buying or selling?
Recent insider activity shows net selling of $211.58M.
Explore More
Continue the stock analysis
Jump to another research area for this company.